Butamirate

Butamirate

Gene therapy
Clinical data
AHFS/Drugs.com	International Drug Names
ATC code	R05DB13 (WHO)
Physiological data
Legal status
Pharmacokinetic data
Protein binding	98%
Elimination half-life	6 hours
Excretion	90% renal
Identifiers
IUPAC name 2-(2-diethylaminoethoxy)ethyl 2-phenylbutanoate
CAS Number	18109-80-3 Y
PubChem Template:Abbreviation	28892
ChemSpider	26873 Y
UNII	M75MZG2236
KEGG	D07594 Y
ChEMBL	ChEMBL1332546
Chemical and physical data
Formula	C18H29NO3
Molar mass	307.428 g/mol
3D model (JSmol)	Interactive image
SMILES O=C(OCCOCCN(CC)CC)C(c1ccccc1)CC
InChI InChI=1S/C18H29NO3/c1-4-17(16-10-8-7-9-11-16)18(20)22-15-14-21-13-12-19(5-2)6-3/h7-11,17H,4-6,12-15H2,1-3H3 Y Key:DDVUMDPCZWBYRA-UHFFFAOYSA-N Y
(verify)

WikiDoc Resources for Butamirate
Articles
Most recent articles on Butamirate Most cited articles on Butamirate Review articles on Butamirate Articles on Butamirate in N Eng J Med, Lancet, BMJ
Media
Powerpoint slides on Butamirate Images of Butamirate Photos of Butamirate Podcasts & MP3s on Butamirate Videos on Butamirate
Evidence Based Medicine
Cochrane Collaboration on Butamirate Bandolier on Butamirate TRIP on Butamirate
Clinical Trials
Ongoing Trials on Butamirate at Clinical Trials.gov Trial results on Butamirate Clinical Trials on Butamirate at Google
Guidelines / Policies / Govt
US National Guidelines Clearinghouse on Butamirate NICE Guidance on Butamirate NHS PRODIGY Guidance FDA on Butamirate CDC on Butamirate
Books
Books on Butamirate
News
Butamirate in the news Be alerted to news on Butamirate News trends on Butamirate
Commentary
Blogs on Butamirate
Definitions
Definitions of Butamirate
Patient Resources / Community
Patient resources on Butamirate Discussion groups on Butamirate Patient Handouts on Butamirate Directions to Hospitals Treating Butamirate Risk calculators and risk factors for Butamirate
Healthcare Provider Resources
Symptoms of Butamirate Causes & Risk Factors for Butamirate Diagnostic studies for Butamirate Treatment of Butamirate
Continuing Medical Education (CME)
CME Programs on Butamirate
International
Butamirate en Espanol Butamirate en Francais
Business
Butamirate in the Marketplace Patents on Butamirate
Experimental / Informatics
List of terms related to Butamirate

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Butamirate (or brospamin) is a cough suppressant.

A study found it to bind to the cough center in the medulla oblongata, more specifically the dextromethorphan-binding site in guinea pig brain with high affinity.

As a 2-(2-diethylaminoethoxy)ethyl ester it is chemically related to oxeladin and pentoxyverine, which are in the same class. (Oxeladin has an additional ethyl group in its carboxylic acid, pentoxyverine has both ethyl groups of oxeladin replaced by one cyclopentyl in the same place.)

References

Template:Respiratory-system-drug-stub